跳至主要内容
临床试验/NL-OMON31424
NL-OMON31424已完成不适用

Hypercoagulable Atrial Appendages in atrial fibrillation (AF): a cross sectional pilot study - Hypercoagulable Atrial Appendages in AF

Academisch Ziekenhuis Maastricht0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Inclusion criteria cases
  • 1. Electrocardiographically established diagnosis of atrial fibrillation
  • 2. Need for thoracic surgery (requiring median sternotomy);Inclusion criteria controls
  • 1. 18 years or older
  • 2. Need for thoracic surgery (requiring median sternotomy)

排除标准

  • Exclusion criteria cases
  • 1. No written informed consent
  • 2. Age under 18 years
  • 3. Severe mitral or aortic valve disease
  • 4. Secondary AF
  • 5. Kidney dysfunction (GFR <30 ml/min, estimated by the Cockroft-Gault formula)
  • 6. Use of experimental study medication in past 6 months;Exclusion criteria controls
  • 1. Electrocardiographically established diagnosis of atrial fibrillation
  • 2. Severe mitral or aortic valve disease
  • 3. No written informed consent
  • 4. Kidney dysfunction (GFR <30 ml/min, estimated by the Cockroft-Gault formula)
  • 5. Use of experimental study medication in past 6 months

研究者

相似试验